Skip to main content
Aytu BioPharma, Inc.SEC 10-Q

Aytu BioPharma enters Merger Agreement to be acquired by Rosemont for $2.70 per share

What happened

3 signals in this filing. On November 16, 2026, Aytu BioPharma entered into an Agreement and Plan of Merger with Rosemont Pharmaceuticals Holdings, Inc., pursuant to which Rosemont will acquire the company via a cash tender offer of $2.70 per...

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 10-Q

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Nov 16, 2026

More SEC 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
1385818
Accession number
0001437749-26-037188
Metric named
$2.70 per share in cash
Timeframe
Current quarter
Quarter
Q1
Filing year
2026
Fiscal year
2027
Period end date
Sep 30, 2026
Why it matters
Integration needs coming
Signal category
Strategic

Extraction

Confidence
High
Relevance
95%
Sentiment
Positive
Detected
Nov 17, 2026
signal_type
sec-10q
signal_subtype
acquisitionAnnounced

Use this data

Get every SEC 10-Q signal for Aytu BioPharma, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Aytu BioPharma, Inc. this week?”

  2. Send it to your own tools

    The Signal API returns SEC 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/142fbdb9-4ce2-44af-96ba-4efcf140caba returns this record as JSON. POST /v1/companies/enrich returns every signal for aytubio.com.

{
  "signal_id": "142fbdb9-4ce2-44af-96ba-4efcf140caba",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionAnnounced",
  "detected_at": "2026-11-17T07:03:29.594+00:00",
  "company": {
    "name": "Aytu BioPharma, Inc.",
    "domain": "aytubio.com"
  },
  "data": {
    "detail": "On November 16, 2026, Aytu BioPharma entered into an Agreement and Plan of Merger with Rosemont Pharmaceuticals Holdings, Inc., pursuant to which Rosemont will acquire the company via a cash tender offer of $2.70 per share. For sellers: Change of control and acquisition transactions often result in integration initiatives, vendor consolidations, and restructuring of existing procurement contracts.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "$2.70 per share in cash"
    },
    "quarter": "Q1",
    "summary": "Aytu BioPharma enters Merger Agreement to be acquired by Rosemont for $2.70 per share",
    "relevance": 0.95,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1385818/000143774926037188/aytu20260930_10q.htm",
    "filing_date": "2026-11-16",
    "filing_year": 2026,
    "fiscal_year": 2027,
    "period_end_date": "2026-09-30",
    "sales_relevance": "Integration needs coming",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.